Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 91 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Giannakoulas, George [Clear All Filters]
(2023).
Chronic hypertension in pregnancy: synthesis of influential guidelines..
J Perinat Med. 49(7), 859-872.
(2021). Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines..
Obstet Gynecol Surv. 76(10), 613-633.
(2021). Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis..
Stroke. 51(6), 1662-1666.
(2020). Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation-the REFLEC-CR Study..
Cardiovasc Drugs Ther. 34(3), 383-389.
(2020). Biochemical and imaging markers in patients with thalassaemia..
Hellenic J Cardiol.
(2020). Duration of interventricular septal shift toward the left ventricle is associated with poor clinical outcome in precapillary pulmonary hypertension: A cardiac magnetic resonance study..
Hellenic J Cardiol. 61(2), 112-117.
(2020). Eisenmenger syndrome: diagnosis, prognosis and clinical management..
Heart. 106(21), 1638-1645.
(2020). Endocarditis as the Cause of Recurrent Fever and Brain Abscess in a Patient with Complex Congenital Heart Disease: A Case Report and Literature Review..
Case Rep Infect Dis. 2020, 7894574.
(2020). From hybrid techniques to "hybrid" mentality: Modern strategies for perimembranous VSD interventions..
Int J Cardiol. 316, 70-71.
(2020). Hospitalizations in adult patients with congenital heart disease: an emerging challenge..
Heart Fail Rev.
(2020).
(2020). Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations..
ESC Heart Fail. 7(4), 1477-1487.
(2020). Non-Vitamin K Antagonist Oral Anticoagulants in Pulmonary Embolism: An Overview of Systematic Reviews..
Curr Pharm Des. 26(23), 2686-2691.
(2020). Non-Vitamin K Oral Anticoagulants in Adults with Congenital Heart Disease: A Systematic Review.
J Clin Med. 9(6),
(2020). Overweight and obesity: time to reconsider their role in heart failure..
Eur J Prev Cardiol. 2047487320933738.
(2020). Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients' Functional Capacity. Study Design and Rationale..
Mediterr J Rheumatol. 31(3), 369-373.
(2020). Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension..
Heart Lung Circ. 29(1), 142-148.
(2020). Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study..
BMJ Open. 10(9), e038012.
(2020). Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD).
Eur Heart J.
(2020). Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation..
J Thromb Thrombolysis.
(2020). Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome..
Am J Cardiol. 133, 7-14.
(2020). Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension..
Int J Cardiol. 306, 187-189.
(2020). Use of Anticoagulants in Patients with Pulmonary Hypertension..
Hamostaseologie. 40(3), 348-355.
(2020).
(2019).
Σελίδες
- 1
- 2
- 3
- 4
- επόμενη ›
- τελευταία »